《房颤抗凝新进展 顾刚》课件.pptVIP

阿司匹林等抗聚药物预防房颤卒中效果较弱，远不如华法林及新型抗凝药物 新型口服抗凝药物较安全，疗效等同或优 华法林，给房颤卒中的预防带来了新的希望 华法林是国内外首选的抗凝药物，如何提高华法林的使用率是我们面临的重要挑战 总 结 谢 谢！ 2、这是房颤最严重而常见的并发症。3、--因此房颤时心房功能丧失，心排血量降低15-30%，而这种情况比率在心衰时更高。4、植入ICD的患者记录到，房颤可诱发室颤导致猝死。 * Five large randomized trials published between 1989 and 1992 evaluated VKA mainly for the primary prevention of thrombo-embolism in patients with non-valvular AF. A sixth trial focused on secondary prevention among patients who had survived non-disabling stroke or TIA. In a meta-analysis, the RR reduction with VKA was highly significant and amounted to 64%, corresponding to an absol